Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1 ...

Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

On August 11, Sensex closed 746.29 points or 0.93 percent higher at 80,604.08, and the Nifty ended 221.75 points or 0.91 ...

The U.S. stock market is climbing toward records after data suggested inflation across the country was a touch better last ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) ('Ligand”) announced today the pricing of $400.0 million aggregate ...

DelveInsight's Tumor-Infiltrating Lymphocyte Therapies Market Size, Target Population, Competitive Landscape & Market ...

DelveInsight's“ Triple Negative Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 165+ ...

With the first half of 2025 in the rearview mirror, the government’s continued focus on False Claims Act (FCA) enforcement shows no signs of ...

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.

Overview of the Market  The global Cystic Fibrosis Market is valued at USD 10.3 Billion in 2024 and is projected to reach a ...

In ‘Culture Club’, Melanie Oliveiro examines a children’s book with a difference, ‘The Adventure Jar’, an illustrated story ...